Education
About Us
Working with TipRanks
Follow Us
Sumitomo Dainippon Pharma Co (DNPUF)
:DNPUF
RESEARCH TOOLSreports
Total Valuation
Sumitomo Dainippon Pharma Co has a market cap or net worth of $1.83B. The enterprise value is $512.70B.
Market Cap$1.83B
Enterprise Value$512.70B
Share Statistics
Sumitomo Dainippon Pharma Co has 397,900,150 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding397,900,150
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Sumitomo Dainippon Pharma Co’s return on equity (ROE) is -2.02 and return on invested capital (ROIC) is -50.95%.
Return on Equity (ROE)-2.02
Return on Assets (ROA)-0.35
Return on Invested Capital (ROIC)-50.95%
Return on Capital Employed (ROCE)-0.90
Revenue Per Employee63.16M
Profits Per Employee-63.25M
Employee Count4,980
Asset Turnover0.35
Inventory Turnover1.10
Valuation Ratios
The current PE Ratio of Sumitomo Dainippon Pharma Co is -0.51. Sumitomo Dainippon Pharma Co’s PEG ratio is >-0.01.
PE Ratio-0.51
PS Ratio0.55
PB Ratio1.03
Price to Fair Value1.03
Price to FCF-0.63
Price to Operating Cash Flow-0.67
PEG Ratio>-0.01
Income Statement
In the last 12 months, Sumitomo Dainippon Pharma Co had revenue of 314.56B and earned -314.97B in profits. Earnings per share was -792.79.
Revenue314.56B
Gross Profit187.98B
Operating Income-354.19B
Pretax Income-323.11B
Net Income-314.97B
EBITDA-281.07B
Earnings Per Share (EPS)-792.79
Cash Flow
In the last 12 months, operating cash flow was -5.67B and capital expenditures -10.96B, giving a free cash flow of -16.63B billion.
Operating Cash Flow-5.67B
Free Cash Flow-16.63B
Free Cash Flow per Share-41.80
Dividends & Yields
Sumitomo Dainippon Pharma Co pays an annual dividend of $0.049, resulting in a dividend yield of ―
Dividend Per Share$0.049
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.36
52-Week Price Change57.69%
50-Day Moving Average4.62
200-Day Moving Average4.03
Relative Strength Index (RSI)34.92
Average Volume (3m)35.00
Important Dates
Sumitomo Dainippon Pharma Co upcoming earnings date is May 13, 2025, TBA Not Confirmed.
Last Earnings DateJan 31, 2025
Next Earnings DateMay 13, 2025
Ex-Dividend DateMar 30, 2023
Financial Position
Sumitomo Dainippon Pharma Co as a current ratio of 0.52, with Debt / Equity ratio of 225.40%
Current Ratio0.52
Quick Ratio0.30
Debt to Market Cap2.60
Net Debt to EBITDA-1.39
Interest Coverage Ratio-82.81
Taxes
In the past 12 months, Sumitomo Dainippon Pharma Co has paid -8.19B in taxes.
Income Tax-8.19B
Effective Tax Rate0.03
Enterprise Valuation
Sumitomo Dainippon Pharma Co EV to EBITDA ratio is -1.96, with an EV/FCF ratio of -2.14.
EV to Sales1.75
EV to EBITDA-1.96
EV to Free Cash Flow-2.14
EV to Operating Cash Flow-2.28
Balance Sheet
Sumitomo Dainippon Pharma Co has $85.39B in cash and marketable securities with ¥156.10B in debt, giving a net cash position of $289.03B billion.
Cash & Marketable Securities$85.39B
Total Debt¥156.10B
Net Cash$289.03B
Net Cash Per Share$726.39
Tangible Book Value Per Share-$602.33
Margins
Gross margin is 60.52%, with operating margin of -112.60%, and net profit margin of -100.13%.
Gross Margin60.52%
Operating Margin-112.60%
Pretax Margin-102.72%
Net Profit Margin-100.13%
EBITDA Margin-89.35%
EBIT Margin-101.36%
Analyst Forecast
The average price target for Sumitomo Dainippon Pharma Co is $5.95, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$5.95
Price Target Upside45.12% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast―